Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer

Published:2020-05 Issue:5 Volume:203 Page:902-909
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Steinberg Ryan L.¹,Thomas Lewis J.²,Brooks Nathan³,Mott Sarah L.⁴,Vitale Andrew⁵,Crump Trafford⁶,Rao Mounica Y.⁷,Daniels Marcus J.⁸,Wang Jonathan⁹,Nagaraju Supriya³,DeWolf William C.⁹,Lamm Donald L.⁷¹⁰,Kates Max⁸,Hyndman M. Eric⁶,Kamat Ashish M.³,Bivalacqua Trinity J.⁸,Nepple Kenneth G.⁵⁴,O’Donnell Michael A.⁵⁴

Affiliation:

1. Department of Urology, University of Texas Southwestern, Dallas, Texas

2. Department of Urology, Cleveland Clinic Foundation, Cleveland, Ohio

3. MD Anderson Cancer Center, Houston, Texas

4. Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa

5. Department of Urology, University of Iowa, Iowa City, Iowa

6. Department of Urology, University of Calgary, Calgary, Alberta, Canada

7. University of Arizona School of Medicine, Phoenix, Arizona

8. Department of Urology, Johns Hopkins University, Baltimore, Maryland

9. Beth Israel Deaconess Medical Center, Boston, Massachusetts

10. BCG Oncology, Phoenix, Arizona

Publisher